Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women

Clinica Chimica Acta

Volumn 369, Issue 1, 2006, Pages 73-77

  Unfer, Taís C ^a   Conterato, Greicy M M ^a   da Silva, João C N ^a   Duarte, Marta M M F ^a   Emanuelli, Tatiana ^b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b Centro de Ciencias Rurais   (Brazil)

Author keywords

Catalase; Glutathione peroxidase; Hormone replacement therapy; Menopause; Superoxide dismutase; Thiobarbituric acid reactive substances

Indexed keywords

ANTIOXIDANT; CATALASE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; GLUTATHIONE PEROXIDASE; LIPID; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; OXIDATIVE STRESS; PREMENOPAUSE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ANTIOXIDANTS; ENZYMES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED;

EID: 33646863906     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.01.006     Document Type: Article

References (41)

1. Bhavnani B.R. Pharmacology of hormonal therapeutic agents. In: Eskin B.A. (Ed). The Menopause Comprehensive Management (2000), The Parthenon Publishing Group, New York 229-256
2. Sowers J.R. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 58 (1998) 617-621
3. Greendale G.A., Lee N.P., and Arriola E.R. The menopause. Lancet 353 (1999) 571-580
4. Stampfer M.J., Willet W.C., Colditz J.A., Rosner B., Speizer F.E., and Hennekens C.H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313 (1985) 1044-1049
5. Liehr J.G. Antioxidant and pro-oxidant actions of estrogens. J Lab Clin Med 128 (1996) 344-345
6. Markides C.S., Roy D., and Liehe J.G. Concentration dependence of pro-oxidant and antioxidant properties of catecholestrogens. Arch Biochem Biophys 360 (1998) 105-112
7. Nathan L., and Chaudhuri G. Antioxidant and pro-oxidant actions of estrogens: potential physiological and clinical implications. Semin Reprod Endocrinol 16 (1998) 309-314
8. Thibodeau P.A., Kachadourian R., Lemay R., Bisson M., Day B., and Paquette B. In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem 81 (2002) 227-236
9. Haliwell B., and Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett 213 (1987) 9-16
10. Huber L.A., Sheffler E., Poll T., Ziegler R., and Dresel H.A. 17β-estradiol inhibits LDL oxidation and cholesteryl macrophages. Free Radic Res Commun 8 (1989) 167-173
11. Ayers S., Abplanalp W., Lui J.H., and Subbiah T.R. Mechanism involved in the protective effect of estradiol-17β on lipid peroxidation and DNA damage. Am J Physiol 274 E (1998) 1002-1008
12. Subbiah M.T.R., Kessel B., Agrawal M., Rajan R., Abplanalp W., and Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 77 (1993) 1095-1097
13. Bednarek-Tupikowaska G., Tupikowski K., Bidzinka B., et al. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol 19 (2004) 57-63
14. Gura T. Estrogen: key player in heart disease among women. Science 269 (1995) 771-773
15. Trevisan M., Browne R., Ram M., et al. Correlates of markers of oxidative status in the general population. Am J Epidemiol 154 (2001) 348-356
16. Ke R.W., Pace D.T., and Ahpkas R.A. Effect of hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women. Fertil Steril 79 (2003) 1118-1122
17. Toniolo P.G., Levitz M., Zeleniuch-Jacquotte A., et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87 (1995) 190-197
18. Cao K., Devanesan P.D., Ramanathan R., Gross M.L., Rogan E.G., and Cavalieri E.L. Covalent binding of catechol estrogens to glutathione catalyzed by horseradish peroxidase, lactoperoxidase, or rat liver microsomes. Chem Res Toxicol 11 (1998) 917-924
19. Liehr J.G. Genotoxic effects of estrogens. Mutat Res 238 (1990) 269-276
20. Fridovich I. The biology of oxygen radicals. Science 201 (1978) 875-880
21. Nohl H. Involvement of free radicals in aging. Br Med Bull 49 (1993) 653-667
22. In: Sies H. (Ed). Antioxidants in Diseases Mechanisms and Therapy (1997), Academic Press, San Diego
23. Gurdol F., OnerYyidooan Y., Yalcyn O., Genc S., and Buyru F. Change in enzymatic antioxidant defense system in blood and endometrial tissue of women after menopause. Res Commun Mol Pathol 97 (1997) 38-46
24. Bednarek-Tupikowaska G., Bohdanowicz-Pawlak A., Bidzinska B., Milewicz A., Antonowicz-Juchniewicz J., and Andrzejak R. Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecol Endocrinol 15 (2001) 298-303
25. Signorelli S.S., Neri S., Sciacchitano S., et al. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53 (2006) 77-82
26. Özden S., Dildar K., Kadir Y.H., and Gülizar K. The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas 38 (2001) 165-170
27. Bureau I., Anderson R.A., Arnaud J., Raysiguier Y., Favier A.E., and Roussel A.M. Trace mineral status in postmenopausal women: impact of hormonal replacement therapy. J Trace Elem Med Biol 16 (2002) 9-13
28. Naziroǧlu M., Simsek M., Simsek H., Aydilek N., Özcan Z., and Atilgan R. The effects of hormone replacement therapy combined with vitamins C and E on antioxidant levels and lipid profiles in postmenopausal women with Type 2 diabetes. Clin Chim Acta 344 (2004) 63-71
29. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
30. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244 (1969) 6049-6055
31. Aebi H. Catalase in vitro. Methods Enzymol 105 (1984) 121-126
32. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-309
33. Ínal M.E., Kanbak G., and Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta 305 (2001) 75-80
34. Kasapoglu M., and Özben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol 36 (2001) 209-220
35. Salo D.C., Pacifini R.E., and Davies K.J.N. Superoxide dismutase is preferentially degraded by a proteolytic system from red blood cells following oxidative modification by hydrogen peroxide. Free Radic Biol Med 5 (1988) 335-339
36. Landis G.N., and Tower J. Superoxide dismutase evolution and life span regulation. Mech Ageing Dev 126 (2005) 365-379
37. Strain J.J. A reassessment of diet and osteoporosis - possible role for copper. Med Hypotheses 27 (1988) 333-338
38. Lowe N.M., Fraser W.D., and Jackson M.J. Is there a potential therapeutic value of copper and zinc for osteoporosis?. Proc Nutr Soc 61 (2002) 181-185
39. Strehlow K., Rotter S., Wassmann S., et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93 (2003) 170-177
40. Feng Z., and Zhang J. Long-term melatonin or 17β-estradiol supplementation alleviates oxidative stress in ovariectomized adult rats. Free Radic Biol Med 39 (2005) 195-204
41. Sugino N., Karube-Harada A., Kashiba S., Takiguchi S., and Kato H. Differential regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase by progesterone withdrawal in human endometrial stromal cells. Mol Hum Reprod 8 (2002) 68-74